diabetes drug weight loss tirzepatide Tirzepatide, the active ingredient behind the popular Zepbound and the drug Mounjaro, has more tricks up its sleeve. Research out this week shows that it can do wonders FDA approves new version of

Studies tracking real-world outcomes show that patients maintaining GLP-1 therapy experience sustained metabolic improvements and weight maintenance even after dose optimization plateaus

"Why the NIH Trial to Assess Chelation Therapy (TACT) should be abandoned"

The April 2024 paper and a comprehensive 2023 Pharmaceuticals review (PMC10224484) detail how peripheral BPC-157 administration produces corresponding central nervous system effects through multiple mechanisms

Individuals sensitive to caffeine, pregnant or lactating women, people with heart conditions, blood pressure concerns, thyroid issues, diabetes, or those taking medication should consult a healthcare professional before use